| Report ID | 275972 |
| Drug Identification Number | 02239630 |
| Brand name | TOBI |
| Common or Proper name | TOBRAMYCIN |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | TOBRAMYCIN |
| Strength(s) | 300MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INHALATION INHALATION |
| Packaging size | 56 AMPULES |
| ATC code | J01GB |
| ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-09-02 |
| Estimated end date | 2026-05-12 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-01-13 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-01-13 | French | Compare |
| v1 | 2026-01-13 | English | Compare |
Showing 1 to 2 of 2